CARB-X supports BioVersys in the fight against antimicrobial resistance with up to almost 9 million dollars
BioVersys receives CARB-X Award of up to US$ 8.92 Million for Development of Novel Antimicrobial Therapies:
Bioversys at the forefront of antibiotic research
Swiss Technology Award 2018
NBE-Therapeutics has obtained a granted patent for the compa...
Opening Events Newly Added Spaces
Opening Lunch Event Newly Added Space – March 13th 2018